GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Total Assets

Concord Biotech (BOM:543960) Total Assets : ₹17,007 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Total Assets?

Concord Biotech's Total Assets for the quarter that ended in Mar. 2024 was ₹17,007 Mil.

During the past 12 months, Concord Biotech's average Total Assets Growth Rate was 3.60% per year. During the past 3 years, the average Total Assets Growth Rate was 12.30% per year.

During the past 5 years, Concord Biotech's highest 3-Year average Total Assets Growth Rate was 22.00%. The lowest was 12.30%. And the median was 17.15%.

Total Assets is connected with ROA %. Concord Biotech's annualized ROA % for the quarter that ended in Mar. 2024 was 21.23%. Total Assets is also linked to Revenue through Asset Turnover. Concord Biotech's Asset Turnover for the quarter that ended in Mar. 2024 was 0.34.

Concord Biotech Total Assets Historical Data

The historical data trend for Concord Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Total Assets Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
9,405.15 11,825.46 13,127.95 15,139.84 17,007.09

Concord Biotech Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Total Assets Get a 7-Day Free Trial 13,127.95 - 15,139.84 15,510.26 17,007.09

Concord Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Concord Biotech's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=15266.455+1740.63
=17,007

Concord Biotech's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=15266.455+1740.63
=17,007

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Biotech  (BOM:543960) Total Assets Explanation

Total Assets is connected with ROA %.

Concord Biotech's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=3451.78/( (15510.255+17007.085)/ 2 )
=3451.78/16258.67
=21.23 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Concord Biotech's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=5597.659/( (15510.255+17007.085)/ 2 )
=5597.659/16258.67
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Concord Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Total Assets
Comparable Companies
BOM:540701 BOM:543434 NSE:ZOTA BOM:531349 NSE:BALAXI BOM:500259 BOM:524717 BOM:532890 BOM:540679 BOM:524663 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
CONCORDBIO:India
Address
Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Website
https://www.concordbiotech.com
Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines